Moderna, US in Covid-19 vaccine deal for up to $1.5 billion
Bloomberg |
Bloomberg| Posted by Susmita Pakrasi Aug 12, 2020 03:51 AM IST
It’s the latest in a string of supply deals reached to stockpile the most advanced vaccines in testing. Moderna shares gained 8.5% to $74.80 in late trading in New York.
Moderna Inc. reached a deal with the US to manufacture and distribute 100 million doses of its experimental vaccine for Covid-19, in a pact valued up to $1.5 billion, the company said Tuesday.
“I’m pleased to announce we’ve reached an agreement with Moderna to manufacture and deliver 100m doses of the coronavirus vaccine candidate,” President Donald Trump said at a White House briefing. “We’re on track to rapidly produce 100 million doses as soon as the vaccine is approved.”
HT launches Crick-it, a one stop destination to catch Cricket, anytime, anywhere. Explore now!
It’s the latest in a string of supply deals reached to stockpile the most advanced vaccines in testing.
Moderna shares gained 8.5% to $74.80 in late trading in New York.
Discover the complete story of India's general elections on our exclusive Elections Product! Access all the content absolutely free on the HT App. Download now! Get Latest World News, Israel-Iran News Live along with Latest News from India at Hindustan Times.
Share this article